[HTML][HTML] Canakinumab in a subgroup of patients with COVID-19
C Ucciferri, A Auricchio, M Di Nicola… - The Lancet …, 2020 - thelancet.com
In a subgroup of patients, severe acute respiratory syndrome corona virus 2 (SARSCoV2)
induces a hyper inflammatory response that leads to acute respiratory dis tress syndrome. 1 …
induces a hyper inflammatory response that leads to acute respiratory dis tress syndrome. 1 …
Canakinumab in a subgroup of patients with COVID-19.
C Ucciferri, A Auricchio, M Di Nicola… - The Lancet …, 2020 - europepmc.org
In a subgroup of patients, severe acute respiratory syndrome corona virus 2 (SARSCoV2)
induces a hyper inflammatory response that leads to acute respiratory dis tress syndrome. 1 …
induces a hyper inflammatory response that leads to acute respiratory dis tress syndrome. 1 …
[引用][C] Canakinumab in a subgroup of patients with COVID-19
C Ucciferri, A Auricchio, M Di Nicola… - The Lancet …, 2020 - pubmed.ncbi.nlm.nih.gov
Canakinumab in a subgroup of patients with COVID-19 Canakinumab in a subgroup of
patients with COVID-19 Lancet Rheumatol. 2020 Aug;2(8):e457-ee458. doi: 10.1016/S2665-9913(20)30167-3 …
patients with COVID-19 Lancet Rheumatol. 2020 Aug;2(8):e457-ee458. doi: 10.1016/S2665-9913(20)30167-3 …
[PDF][PDF] Canakinumab in a subgroup of patients with COVID-19
C Ucciferri, A Auricchio, M Di Nicola… - THE LANCET …, 2020 - ricerca.unich.it
In a subgroup of patients, severe acute respiratory syndrome corona virus 2 (SARSCoV2)
induces a hyper inflammatory response that leads to acute respiratory dis tress syndrome. 1 …
induces a hyper inflammatory response that leads to acute respiratory dis tress syndrome. 1 …
[HTML][HTML] Canakinumab in a subgroup of patients with COVID-19
C Ucciferri, A Auricchio, M Di Nicola… - The Lancet …, 2020 - ncbi.nlm.nih.gov
In a subgroup of patients, severe acute respiratory syndrome corona virus 2 (SARSCoV2)
induces a hyper inflammatory response that leads to acute respiratory dis tress syndrome. 1 …
induces a hyper inflammatory response that leads to acute respiratory dis tress syndrome. 1 …
[PDF][PDF] Canakinumab in a subgroup of patients with COVID-19
C Ucciferri, A Auricchio, M Di Nicola, N Potere… - FASEB J, 2019 - ricerca.unich.it
In a subgroup of patients, severe acute respiratory syndrome corona virus 2 (SARSCoV2)
induces a hyper inflammatory response that leads to acute respiratory dis tress syndrome. 1 …
induces a hyper inflammatory response that leads to acute respiratory dis tress syndrome. 1 …